The Flowr Corporation

The Flowr Corporation

FLWR.V
The Flowr CorporationCA flagToronto Stock Exchange Ventures
0.03
CAD
- -
- -
The Flowr Corporation
FLWR.V
(Toronto Stock Exchange Ventures)

Recent

price

0.03

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
The Flowr Corporation (TSXV:FLWR) cultivates, produces and sells premium cannabis products primarily in Canada with historical operations in Portugal; the company offers dried flowers, pre-rolls, oils and other formats including vaporization, ingestion and topical products for medical and recreational markets. Founded in 2016 and headquartered in Toronto, Ontario, Flowr operates through its Canadian segment focused on licensed production at facilities such as the Kelowna campus in British Columbia, targeting high-yield premium flower and adjacent derivatives; it previously managed the Holigen segment in Portugal encompassing an EU GMP-certified indoor facility in Sintra and an outdoor site in Aljustrel before completing a $35 million divestiture of Holigen Holdings to Akanda Corp. in 2022. Geographically, Flowr serves the Canadian adult-use and medical cannabis sectors nationwide alongside past international medical exports from Europe, emphasizing high-THC strains like BC Pink Kush and BC Black Cherry. Recent major changes include the 2022 sale of its Okanagan operations and research facility to Avant Brands, a shift that streamlined its balance sheet amid creditor proceedings; the company also divested the Kelowna Research Station R&D site to Hawthorne Canada and continues to prioritize domestic premium production following earlier international expansions and funding rounds such as a C$15.9 million bought deal in 2021.